Anti-Cancer Agents in Medicinal Chemistry
Title:Preface
Volume: 20 Issue: 1
Author(s): Michelle Prudhomme
Affiliation:
Export Options
About this article
Cite this article as:
Prudhomme Michelle , Preface, Anti-Cancer Agents in Medicinal Chemistry 2020; 20 (1) . https://dx.doi.org/10.2174/187152062001200224141924
DOI https://dx.doi.org/10.2174/187152062001200224141924 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
3
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Anticancer Therapeutic Strategies Based on CDK Inhibitors
Current Pharmaceutical Design Signaling Pathways Modulating Dependence of Lung Cancer on Mutant Epidermal Growth Factor Receptor and Mechanisms of Intrinsic and Acquired Resistance to Tyrosine Kinase Inhibitors
Current Pharmaceutical Design NMR Structural Studies of Oligosaccharides Related to Cancer Processes
Anti-Cancer Agents in Medicinal Chemistry Development of Novel Therapeutic Drugs in Humans from Plant Antimicrobial Peptides
Current Protein & Peptide Science Subject Index To Volune 2
Current Cancer Therapy Reviews SHP-1 in Cell-Cycle Regulation
Anti-Cancer Agents in Medicinal Chemistry Metalloproteinases Suppression Driven by the Curcumin Analog DM-1 Modulates Invasion in BRAF-Resistant Melanomas
Anti-Cancer Agents in Medicinal Chemistry Silencing of Disease-related Genes by Small Interfering RNAs
Current Molecular Medicine A Broader Perspective on Personalized Medicine: Lessons from Discourse Analysis and Knowledge Translation
Current Pharmacogenomics and Personalized Medicine Design, Synthesis and In Vitro Evaluation of 4-Androstene-3,17-dione/Adenosine Hybrid Compounds as Bisubstrate Inhibitors of Type 3 17β-Hydroxysteroid Dehydrogenase
Medicinal Chemistry Methods for Hydroxamic Acid Synthesis
Current Organic Chemistry The Role of Reactive Oxygen Species in Tumor Treatment and its Impact on Bone Marrow Hematopoiesis
Current Drug Targets “Virostatics” as a Potential New Class of HIV Drugs
Current Pharmaceutical Design Bioactive Milk Lipids
Current Nutrition & Food Science <sup>99m</sup>Tc-EDDA/HYNIC-TOC is a New Opportunity in Neuroendocrine Tumors of the Lung (and in other Malignant and Benign Pulmonary Diseases)
Current Radiopharmaceuticals Subject Index To Volume 7
Current Drug Metabolism The Heme-Heme Oxygenase System in Wound Healing; Implications for Scar Formation
Current Drug Targets In Silico and Biochemical Analyses Identify Quinone Reductase 2 as a Target of Piceatannol
Current Medicinal Chemistry Targeting Cancer Stem Cells with Natural Products
Current Drug Targets The Therapeutic Impact of Manipulating Microbiota in Inflammatory Bowel Disease
Current Pharmaceutical Design